Cited by 166Wnt/β-catenin signaling in development and cancerProstate Cancer Treatment and ResearchEstrogen and related hormone effects

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Liganded Androgen Receptor Interaction with β-Catenin

Open access

Abstract

A yeast two-hybrid assay was employed to identify androgen receptor (AR) protein partners in gonadotropin-releasing hormone neuronal cells. By using an AR deletion construct (AR-(Delta371-485)) as a bait, beta-catenin was identified as an AR-interacting protein from a gonadotropin-releasing hormone neuronal cell library. Immunolocalization of co-transfected AR and FLAG-beta-catenin demonstrated that FLAG-beta-catenin was predominantly cytoplasmic in the absence of androgen. In the presence of 5alpha-dihydrotestosterone, FLAG-beta-catenin completely co-localized to the nucleus with AR. This effect was specific to AR because liganded progesterone, glucocorticoid, or estrogen alpha receptors did not translocate FLAG-beta-catenin to the nucleus. Agonist-bound AR was required because the AR antagonists casodex and hydroxyflutamide failed to translocate beta-catenin. Time course experiments demonstrated that co-translocation occurred with similar kinetics. Nuclear co-localization was independent of the glycogen synthase kinase-3beta, p42/44 ERK mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways because inhibitors of these pathways had no effect. Transcription assays demonstrated that liganded AR repressed beta-catenin/T cell factor-responsive reporter gene activity. Conversely, co-expression of beta-catenin/T cell factor repressed AR stimulation of AR-responsive reporter gene activity. Our data suggest that liganded AR shuttles beta-catenin to the nucleus and that nuclear interaction of AR with beta-catenin may modulate transcriptional activity in androgen target tissues.

Overview

Integrity signals

Registry

Crossref · 10.1074/jbc.m200545200

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 66 references

Research works printed but not linked: 14

  1. Kousteni, 2001, Cell., 104, 719
  2. Roche, 1992, Mol. Endocrinol., 6, 2229
  3. Adler, 1993, Mol. Cell. Biol., 13, 6326
  4. Scarlett, 1995, Mol. Endocrinol., 9, 413
  5. Jorgensen, 2001, Mol. Endocrinol., 15, 1496
  6. Jorgensen, 2001, Mol. Endocrinol., 15, 1505
  7. Curtin, 2001, Mol. Endocrinol., 15, 1906
  8. Issack, 1998, Cell Growth Differ., 9, 837
  9. Fukuchi, 1998, Cancer Res., 58, 3526
  10. Garcia-Rostan, 1999, Cancer Res., 59, 1811
  11. Mirabelli-Primdahl, 1999, Cancer Res., 59, 3346
  12. Palacios, 1998, Cancer Res., 58, 1344
  13. Voeller, 1998, Cancer Res., 58, 2520
  14. Truica, 2000, Cancer Res., 60, 4709

Cited by

Sorted by citations

See all 166

Metadata

Authors
Pawlowski, J. E., Ertel, J. R., Allen, M. P., Xu, M., Butler, C., Wilson, E. M., & Wierman, M. E.
Affiliations
  • Veterans Health Administration (US)
  • University of Colorado Health (US)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
Wierman, Margaret E.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-06
Volume
277
Issue
23
Pages
20702-20710
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2033728702
Cited by
166
References
66
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 10 · 2012: 4
FWCI
6.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
androgen receptor, β-catenin, protein-protein interaction, nuclear translocation, dihydrotestosterone, GnRH neurons, transcriptional repression, T-cell factor, bicalutamide, hydroxyflutamide, androgen receptor antagonists, transcriptional regulation
MeSH terms
Androgen Antagonists, Animals, Cell Line, Cell Nucleus, Cytoskeletal Proteins, Immunohistochemistry, Ligands, Neurons, Precipitin Tests, Promoter Regions, Genetic, Receptors, Androgen, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Progesterone, Transcription, Genetic, Blotting, Western, Trans-Activators, COS Cells, Two-Hybrid System Techniques, Protein Transport, Estrogen Receptor alpha, beta Catenin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review